14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CELG
Delisted

Celgene Corporation Stock Predictions

NASDAQ Stock Exchange
Open Broker Account
$108.24
+0 (+0%)
At Close: Jan 16, 2020
Forecast Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 20 May 2024

CELG Predictions History

6 years ago
 JuanC Villegas predicted that CELG for 2017-10-13 is going $137.71 (-0.57%)

6 years ago
 JS predicted that CELG for 2017-07-12 is going $132.06 (-1.12%)

6 years ago
 JuanC Villegas predicted that CELG for 2017-07-12 is going $132.76 (0.39%)

6 years ago
 JuanC Villegas predicted that CELG for 2017-06-23 is going $133.22 (-0.34%)

7 years ago
 StockInvest predicted that CELG for 2016-08-16 is going $113.64 (-0.85%)

Click to get the best stock tips daily for free!

About Celgene Corporation

Celgene Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhib... CELG Profile

Golden Star

Ticker Date Change Price
LYV May 15 0.114% $96.48
RL May 15 0.539% $166.98
PAGS May 15 0.157% $12.74
EVBG May 15 0.230% $34.79
INBX May 15 0.96% $34.37
CME May 14 1.11% $210.80
VGIT May 14 0.173% $57.83
VCLT May 14 0.726% $75.73
BNDX May 14 0.267% $48.60
FIXD May 14 0.303% $42.89
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT